Alberto Fusi
Experienced in WT1-Related Wilms Tumor Syndromes

Alberto Fusi

St George's University Hospitals NHS Foundation Trust
London, ENG, GB 

Experienced in WT1-Related Wilms Tumor Syndromes
St George's University Hospitals NHS Foundation Trust
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Alberto Fusi practices in London, United Kingdom. Mr. Fusi is rated as an Experienced expert by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melanoma, Small Cell Lung Cancer (SCLC), WT1-Related Wilms Tumor Syndromes, and Lung Cancer.

His clinical research consists of co-authoring 34 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of WT1-Related Wilms Tumor Syndromes.

Gender
Male

Locations

St George's University Hospitals NHS Foundation Trust
London, ENG, United Kingdom
Other Locations
Manchester, ENG M204BX, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

A Study of the Safety and Efficacy of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma
A Study of the Safety and Efficacy of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma
Enrollment Status: Completed
Publish Date: April 29, 2024
Intervention Type: Drug
Study Drugs: Nivolumab, Ipilimumab, IMM-101
Study Phase: Phase 2

34 Total Publications

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM).
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 05, 2023
View All 34 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fusi's expertise for a condition
ConditionClose
    • Distinguished
    • Melanoma
      Mr. Fusi is
      Distinguished
      . Learn about Melanoma.
      See more Melanoma experts
    • Advanced
    • Small Cell Lung Cancer (SCLC)
      Mr. Fusi is
      Advanced
      . Learn about Small Cell Lung Cancer (SCLC).
      See more Small Cell Lung Cancer (SCLC) experts
    • Experienced
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
      Mr. Fusi is
      Experienced
      . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
      See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
    • Lung Cancer
      Mr. Fusi is
      Experienced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Trophoblastic Tumor Placental Site
      Mr. Fusi is
      Experienced
      . Learn about Trophoblastic Tumor Placental Site.
      See more Trophoblastic Tumor Placental Site experts
    • Vaginal Cancer
      Mr. Fusi is
      Experienced
      . Learn about Vaginal Cancer.
      See more Vaginal Cancer experts
    • WT1-Related Wilms Tumor Syndromes
      Mr. Fusi is
      Experienced
      . Learn about WT1-Related Wilms Tumor Syndromes.
      See more WT1-Related Wilms Tumor Syndromes experts
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved